BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu S, Li D, Zhang N, Ni S, Sun M, Wang L, Xiao H, Liu D, Liu J, Yu Y, Zhang Z, Yeung STY, Zhang S, Lu A, Zhang Z, Zhang B, Zhang G. Drug discovery of sclerostin inhibitors. Acta Pharm Sin B 2022;12:2150-70. [PMID: 35646527 DOI: 10.1016/j.apsb.2022.01.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Zhang H, Chan DWH, Ma Y, Lu A, Yu S, Zhang B, Zhang G. Strategies for developing long-lasting therapeutic nucleic acid aptamer targeting circulating protein: The present and the future. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1048148] [Reference Citation Analysis]
2 Chen L, Gao G, Shen L, Yue H, Zhang G, Zhang Z, Kushnir MM. Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases. Disease Markers 2022;2022:1-8. [DOI: 10.1155/2022/7902046] [Reference Citation Analysis]